Studies on the Cornea and Lens

“This book provides an in-depth analysis of basic science concepts pertinent for clinician-scientists working in the field of ocular diseases. … the book is intended for residents, practitioners, and researchers. … This is an in-depth analysis of basic science concepts for corneal and lenticular diseases.” (Stephen M. Holland, Doody's Book Reviews, July, 2015)

Dr. Mark Babizhayev is a bio-physicist and holds a PhD  in Biophysics and Pathophysiology from the Moscow Helmholtz Research Institute of Eye Diseases, Moscow, Russia. He has dedicated many years to scientific research and has written more than 102 published articles and has fifteen patents to his name. The recipient of numerous awards, Dr. Babizhayev is currently Executive Director of Innovative Vision Products, Inc., Delaware, USA, Senior Research Investigator at Moscow Helmholtz Research Institute of Eye Diseases, and Scientific Consultant at EXSYMOL SAM, Monte Carlo, Monaco, and Bruschettini  SRL, Genoa, Italy. He is also one of the principal researchers involved in the development of a breakthrough for the treatment and prevention of senile cataract.

Dr. David Wan-Cheng Li is an Associate Professor of Ophthalmology and Visual Sciences in the Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, an elected Lotus Scholar Professor of Cell and Developmental Biology of China's Hunan Normal University by Hunan Province Government, and a Visiting Professor of Ophthalmology and Visual Sciences in the State Key Laboratory in the Zhongshan Ophthalmic Center of Sun Yat-Sen University Medical Center, Guangzhou, China. He received his PhD from University of Washington, Seattle, USA, and completed his postdoctoral training at Columbia University, New York, USA. His scientific contributions include the major discoveries that stress-induced apopto

Dr. Anne Kasus-Jacobi is Assistant Professor of Pharmaceutical Sciences and adjunct faculty in the Departments of Neuroscience and Physiology at the University of Oklahoma Health Sciences Center, Oklahoma City, USA. She was previously Assistant Professor of Ophthalmology at the Dean McGee Eye Institute in the University of Oklahoma Health Sciences Center. She received her PhD in Endocrinology from the University of Paris, France, and continued her postdoctoral training in the laboratory of Drs. Michael Brown and Joseph Goldstein at the University of Texas Southwestern Medical Center, Dallas, USA. Dr. Kasus-Jacobi’s current interests include the development of innovative peptide treatments for corneal wounds and antibiotic-resistant bacterial infections. She is a member of the Association for Research in Vision and Ophthalmology and serves as an editorial board member of the Journal of Ocular Diseases and Therapeutics .

Dr. Lepša Žorić works in clinical ophthalmology on

Dr. Jorge L. Alió is Professor and Chairman of Ophthalmology at the Miguel Hernández University, Alicante, Spain, and formerly chairman of Ophthalmology at the University of Alicante, Spain. He has been appointed with several visiting professorships at universities in the United States and Europe. He attended the Complutense University of Madrid, Spain, where he received a medical degree and a PhD in biological thermodynamics and its application in the study of ophthalmic pathology. Recipient of the 2012 Lifetime Achievement Award from the International Society of  Refractive Surgery, Dr. Alió’s main research interests include refractive, lens and corneal surgery, ocular inflammation and preventative ophthalmology. His main contributions have been in the area of excimer laser refractive surgery, microincisional lens surgery, and multifocal accommodative and premium IOLs.